Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Determination of quality of pyridoxal-5'-phosphate enzyme preparations by spectroscopic methods

Drsata J, Bousová I, Malon P.

Language English Country Great Britain

Document type Comparative Study

E-resources Online

NLK ScienceDirect (archiv) from 1993-01-01 to 2009-12-31

The present study evaluates purified aspartate transaminase (AST, EC 2.6.1.1) preparations from three commercial sources. The enzyme molecule contains pyridoxal-5'-phosphate coenzyme (PLP), which provides AST characteristic absorption spectra in the wavelength range of 300-500 nm. The coenzyme bound in the active site also shows circular dichroism (CD) spectra in the same range. Besides, AST like other proteins may be modified in vitro or in vivo by reactions with other molecules, e.g. reactive sugars, and may form fluorescent products (advanced glycation end products, AGE). Spectroscopic methods were used to assess the quality of AST preparations from three different sources, Serva, Roche, and Sigma. Absorption spectra showed that the peak 360 nm characteristic of the active PLP form of AST prevailed in the Serva and Sigma preparations, while 330 nm was the major peak in the Roche preparation. CD spectra demonstrated the major maximum at 360 nm in the Serva and Roche samples, thus suggesting the predominance of the active PLP form in both preparations. The Sigma sample showed a CD profile less characteristic of AST. Fluorescence measurements revealed formation of AGE in the case of the Roche preparation, while fluorescence of the other two preparations was low. In general, the Serva sample presented the most convenient properties of purified AST among the preparations tested. The results will be used for the selection of a commercial enzyme preparation applicable in our future spectroscopic studies of glycation of AST as a model protein and in our research of the influence of antioxidants on this process.

000      
00000naa 2200000 a 4500
001      
bmc07520438
003      
CZ-PrNML
005      
20111210131126.0
008      
090402s2005 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Dršata, Jaroslav, $d 1943- $7 jn20000400552
245    10
$a Determination of quality of pyridoxal-5'-phosphate enzyme preparations by spectroscopic methods / $c Drsata J, Bousová I, Malon P.
314    __
$a Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Heyrovského 1203, CZ-50005 Hradec Králové, Czech Republic. drsata@faf.cuni.cz
520    9_
$a The present study evaluates purified aspartate transaminase (AST, EC 2.6.1.1) preparations from three commercial sources. The enzyme molecule contains pyridoxal-5'-phosphate coenzyme (PLP), which provides AST characteristic absorption spectra in the wavelength range of 300-500 nm. The coenzyme bound in the active site also shows circular dichroism (CD) spectra in the same range. Besides, AST like other proteins may be modified in vitro or in vivo by reactions with other molecules, e.g. reactive sugars, and may form fluorescent products (advanced glycation end products, AGE). Spectroscopic methods were used to assess the quality of AST preparations from three different sources, Serva, Roche, and Sigma. Absorption spectra showed that the peak 360 nm characteristic of the active PLP form of AST prevailed in the Serva and Sigma preparations, while 330 nm was the major peak in the Roche preparation. CD spectra demonstrated the major maximum at 360 nm in the Serva and Roche samples, thus suggesting the predominance of the active PLP form in both preparations. The Sigma sample showed a CD profile less characteristic of AST. Fluorescence measurements revealed formation of AGE in the case of the Roche preparation, while fluorescence of the other two preparations was low. In general, the Serva sample presented the most convenient properties of purified AST among the preparations tested. The results will be used for the selection of a commercial enzyme preparation applicable in our future spectroscopic studies of glycation of AST as a model protein and in our research of the influence of antioxidants on this process.
650    _2
$a zvířata $7 D000818
650    _2
$a pyridoxalfosfát $x analýza $x chemická syntéza $x normy $7 D011732
650    _2
$a fluorescenční spektrometrie $x metody $7 D013050
650    _2
$a prasata $7 D013552
650    _2
$a financování organizované $7 D005381
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Boušová, Iva $7 stk2007405423
700    1_
$a Maloň, Petr $7 xx0159114
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $g Roč. 37, č. 5 (2005), s. 1173-1177 $x 0731-7085
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20090716091307 $b ABA008
999    __
$a ok $b bmc $g 638241 $s 491040
BAS    __
$a 3
BMC    __
$a 2005 $b 37 $c 5 $d 1173-1177 $i 0731-7085 $m Journal of pharmaceutical and biomedical analysis $x MED00002894
LZP    __
$a 2009-B2/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...